What is Bioventus's investing cash flow?

Bioventus (BVS) reported investing cash flow of -$574K in Q1 2026.

How has Bioventus's investing cash flow changed year-over-year?

Bioventus's investing cash flow increased by 30.5% year-over-year, from -$826K to -$574K.

What is the long-term trend for Bioventus's investing cash flow?

Over 3 years (2021 to 2025), Bioventus's investing cash flow has grown at a -77.5% compound annual growth rate (CAGR), from -$283.76M to -$3.25M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Bioventus BVS Investing Cash Flow

Investing Cash Flow at other companies

StrykerSYK

-$185M+95.5%

Orthofix Medical Inc.OFIX

-$10.52M-56.1%

Zimmer Biomet HoldingsZBH

-$159M-50.0%

MedtronicMDT

-$917M-87.1%

Globus MedicalGMED

-$182.67M-239%

Organogenesis Holdings Inc.ORGO

-$3.15M+13.2%

Other financials

Income statement

See full

Revenue$132.1M+6.6%

Gross profit$90.8M+9.3%

Operating income$8.4M+72.8%

Net income$3.1M+218%

EPS (diluted)$0.04+200%

Balance sheet

See full

Cash & equivalents$35.8M+57.2%

Total debt$288.4M-21.2%

Total equity$188.9M+27.5%

Total assets$650.5M-5.9%

Cash flow

See full

Operating cash flow$8.9M+146%

CapEx$574.0K-30.5%

Free cash flow$8.4M+141%

Valuation

See full

Market cap$659.19M+51.7%

Enterprise value$911.76M+17.2%

P/E23.1×—

P/S1.1×+0.4×

Profitability

See full

Gross margin68.7%+1.2pp

Operating margin10%—

Net margin4.9%+3.2pp

FCF margin17.5%+13.2pp

Returns & leverage

See full

Return on equity16.9%+10.9pp

Debt / equity1.5×-0.9×

Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bioventus's investing cash flow?: Bioventus (BVS) reported investing cash flow of -$574K in Q1 2026.
How has Bioventus's investing cash flow changed year-over-year?: Bioventus's investing cash flow increased by 30.5% year-over-year, from -$826K to -$574K.
What is the long-term trend for Bioventus's investing cash flow?: Over 3 years (2021 to 2025), Bioventus's investing cash flow has grown at a -77.5% compound annual growth rate (CAGR), from -$283.76M to -$3.25M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.